SELL TO SCIENTISTS.

Industry Profile

Nanomedicine

Target researchers — Pharmaceutical scientists, biophysicists, and cell biologists specializing in lipid nanoparticle design, polymeric micelles, dendrimers, inorganic nanocarriers, active and passive tumor targeting, and in vivo biodistribution profiling

Nanomedicine applies nanoscale drug carriers such as LNPs, polymeric micelles, and dendrimers to improve the delivery, pharmacokinetics, and tumor accumulation of small molecules, nucleic acids, and biologics. The siRNA delivery revolution drew heavily from university polymer chemistry and biophysics labs whose LNP and conjugate chemistry innovations are now licensed worldwide.

$9.2B Market size
10 Key companies
6 Use cases

Key Companies

Silence Therapeutics Arrowhead Pharmaceuticals Alnylam Pharmaceuticals Serina Therapeutics Polymun Scientific Tarveda Therapeutics NanoCarrier Precision BioSciences Cerephex Noven Nuvation Bio

Use Cases

01

LNP-siRNA delivery IP licensing

02

Tumor-targeted nanoparticle co-development

03

PEGylation chemistry access

04

Nanoparticle surface functionalization consulting

05

In vivo imaging probe supply

06

Active targeting ligand library licensing

Free to browse · subscribe to unlock the full dataset

See the full dataset.

Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.

Sign Up Free →
Get Started